Saturday, November 7, 2026

Damora Therapeutics moves corporate domicile to Cayman Islands   

Damora Therapeutics, a United States biotechnology company focused on treatments for blood disorders, has completed its corporate redomestication from the state of Delaware to the Cayman Islands, with the change taking legal effect on 16 July.

The move reinforces the Cayman Islands’ standing as a preferred jurisdiction for international life sciences and biotechnology firms seeking a well-regulated, commercially flexible corporate domicile. The country has long attracted companies in the financial services and alternative investments sectors, and the arrival of a Nasdaq-listed biotech adds further breadth to its corporate registry.

Under the terms of the redomestication, each share of common stock in the Delaware entity was automatically converted into one ordinary share of the newly domiciled Cayman company, at a par value of $0.00001 per share. Preferred shares were similarly converted on a one-for-one basis into the corresponding series of Cayman preferred shares. The transaction had been endorsed by Damora’s board of directors and was subsequently ratified by shareholders at a special meeting held in February.

The company’s ordinary shares will continue to be listed on the Nasdaq exchange under the ticker symbol “DMRA”. From 20 July, trading will take place under a new CUSIP identifier, G2646Y104, reflecting the change in domicile. Damora said the redomestication would have no effect on its business operations, management structure, or balance sheet.

Damora is developing a pipeline of biological therapies targeting myeloproliferative neoplasms, which are rare blood cancers driven by mutations in the calreticulin gene, including essential thrombocythaemia and myelofibrosis.

The company said it expects multiple programmes to enter clinical development before the end of the year. It is also seeking to bring forward treatments with broad mutation coverage for conditions in which existing therapies offer limited disease-modifying benefit.

RELATED ARTICLES

Most Popular

Reset password

Enter your email address and we will send you a link to change your password.

Get started with your account

to save your favourite homes and more

Sign up with email

Get started with your account

to save your favourite homes and more

By clicking the «SIGN UP» button you agree to the Terms of Use and Privacy Policy

Create an agent account

Manage your listings, profile and more

By clicking the «SIGN UP» button you agree to the Terms of Use and Privacy Policy

Create an agent account

Manage your listings, profile and more

Sign up with email